Genomic Biopharma

Genomic Biopharma Inc., created by Dante Genomics, is a drug discovery and development company that has established a series of drug programs, focusing on bringing treatments and therapies for infectious and rare diseases to market. The company has developed its pipeline based on discoveries from Dante Genomics' proprietary whole-genome database. Genomic Biopharma's core technology, GBI AI, uses predictive algorithms and genomic data mining to support the identification of novel RNA-based therapeutic approaches.